Sermes CRO Deploys Oracle Clinical Applications to Support Growth
Sermes a contract research organization (CRO) based in Madrid, Spain, has deployed Oracle Clinical applications to support a new business unit focused on clinical trial data management, as well as plans for continued expansion in the global clinical trial market.
Sermes CRO Deploys Oracle Clinical Applications to Support Growth
Contract Research Organization Gains Electronic Data Capture Capabilities to Speed Information Capture and Streamline Regulatory Reporting
Redwood Shores, CA-November 24, 2008
Sermes CRO<http://www.sermes.org/principal.htm>, a contract research organization (CRO) based in Madrid, Spain, has deployed Oracle® Clinical applications to support a new business unit focused on clinical trial data management, as well as plans for continued expansion in the global clinical trial market.
The company, which manages approximately eight to 12 global clinical trials annually and is involved in more than 300 studies each year, is expanding its presence in Europe through alliances with other CROs in the region as well as the launch of expanded clinical trial data management capabilities.
To support its expansion initiative, Sermes CRO required a robust, proven and highly reliable and scalable clinical data management system to replace its legacy Access Clinical Software solution.
Sermes is deploying Oracle Clinical<http://www.oracle.com/industries/life_sciences/oracle-clinical.html>, Oracle Remote Data Capture 4.5.3<http://www.oracle.com/industries/life_sciences/rdc-onsite-datasheet.pdf> and Oracle Thesaurus Management System <http://www.oracle.com/industries/life_sciences/oracle-thesaurus-management-system-data-sheet.pdf> to facilitate process automation; effectively capture, manage and report patient data; and facilitate regulatory compliance.
Sermes CRO plans to launch two global clinical trials using Oracle Clinical and Oracle Remote Data Capture in early 2009 – the company’s first
studies using the newly deployed applications.
PharmaSOL<http://solutions.oracle.com/partners/pharmasol>, an Oracle Certified Partner, worked with Sermes to deploy and validate the system to comply with U.S. Food and Drug Administration as well as European regulatory agency requirements.
PharmaSOL used the innovative “rapidLIVE” approach, which allowed for a quicker implementation of the full suite. The streamlined training and validation package simplified the system rollout and meant that users were immediately productive with the applications.
Supporting Quotes
· “As we prepared to expand our services, we needed a reliable and feature-rich clinical data management system that the pharmaceutical industry knew and trusted. Oracle Clinical applications provide us with the functionality we need to help ensure quality services to pharmaceutical organizations through accurate clinical data capture and precise information management,” said Anna Jurczynska, Director of Business Development, Sermes CRO.
· “Oracle is helping emerging organizations, like Sermes CRO, accelerate insights for better health by offering proven, market-trusted solutions that speed system validation processes and support credentialing efforts as they expand the scope and reach of their services,” said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences Global Business Unit. “With Oracle Clinical applications, Sermes CRO can deliver value to clients by offering the industry’s most robust electronic data capture and clinical data management capabilities.”
About Oracle
Oracle (NASDAQ: ORCL) is the world’s largest enterprise software company. For more information about Oracle, please visit our Web site at
http://www.oracle.com.
Trademark
Oracle is a registered trademark of Oracle Corporation and/or its affiliates. Other names may be trademarks of their respective owners.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
